Effectiveness of Low-Level Laser Therapy (LLLT) Versus Orofacial Physical Therapy for Temporomandibular Dysfunction. a Randomized Controlled Trial

NCT06772012 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-01-13

No results posted yet for this study

Summary

This study will investigate if Low-Level Laser Therapy (LLLT) is more effective than Orofacial Physical Therapy for treating Temporomandibular Dysfunction. By conducting a randomized controlled trial, it aims to fill gaps in current knowledge, improve TMD treatment options, and enhance patient outcomes.

Conditions

  • Temporomandibular Dysfunction

Interventions

OTHER

Low-Level Laser Therapy (LLLT)

* Frequency: LLLT was administered 3 times per week. * Duration: Each session lasted approximately 15-20 minutes. * Total Duration: The therapy was provided for a total of 6 weeks.(50)

OTHER

Orofacial Physical Therapy

* Frequency: Orofacial physical therapy sessions were conducted 3 times per week. * Duration: Each session lasted around 30-40 minutes. * Total Duration: The therapy was provided for a total of 6 weeks. * Components: * Manual Therapy: Included techniques such as joint mobilization, soft tissue manipulation, and muscle stretching. * Therapeutic Exercises: Focused on strengthening, coordination, and improving mobility of the masticatory muscles. * Postural Training: Addressed poor posture and cervical muscle spasm.(50)

Sponsors & Collaborators

  • Bahria University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-09-30
Completion
2024-12-02

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06772012 on ClinicalTrials.gov